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The mechanisms by which T helper 17 (Th17) cells contribute to autoimmune encephalomyelitis are likely
diverse and not fully elucidated. In this issue of Immunity, Siffrin et al. (2010) propose that Th17 cells engage
in direct interactions with neurons, leading to neuronal dysfunction and exacerbation of disease.Multiple sclerosis (MS) is an autoimmune
disease inwhich an inappropriate immune
response to central nervous system (CNS)
antigens leads to demyelination and,
ultimately, axonal injury. Experimental
autoimmune encephalomyelitis (EAE), a
common animal model for MS, has been
instrumental for dissecting the contri-
butions of various hematopoietic and
nonhematopoietic cell types to the patho-
genesis of this disease. Over the past
decade, multiple lines of evidence have
demonstrated a critical role for T helper
17 (Th17) effector T cell responses and,
in particular, their effector gene product,
IL-17A, in the development of EAE
(Komiyama et al., 2006). Although it is
surely more complex in its pathophysi-
ology than these EAE models, emerging
evidence suggests that Th17 responses
may also underlie critical aspects of MS
in humans, thus emphasizing the impor-
tance of elucidating the function of these
cells during CNS inflammation (Kebir
et al., 2007).
The mechanisms by which Th17 cells
contribute to autoimmunity, and MS in
particular, have been the subject of inten-
sive study. Although the precise role of
these cells in EAE remains controversial,
several recent studies have begun to
define the Th17 cell-related cellular andmolecular pathways involved in disease
pathogenesis. Following activation and
differentiation in secondary lymphoid
organs, Th17 cells expressing the chemo-
kine receptor, CCR6, enter systemic
circulation and appear to invade the
CNS through epithelial cells of the choroid
plexus, which express the CCR6 ligand,
CCL20 (Reboldi et al., 2009). Once local-
ized within the CNS, these autoreactive
Th17 cells presumably interact with
antigen-presenting cells (APCs) present-
ing myelin-derived antigens, leading to
production of effector cytokines, such as
IL-17A. In addition to Th17 cells, other
cell types, including gd T cells, are poten-
tial sources of IL-17 in the CNS (Sutton
et al., 2009). Several studies propose
that IL-17A mediates the major patho-
genic functions of Th17 in EAE, support-
ing a model in which the local production
of IL-17A leads to activation of endothelial
cells within the CNS, thereby disrupting
the blood brain barrier (Kebir et al.,
2007), and upregulation of proinflamma-
tory chemokines and cytokines from
CNS-resident astrocytes or other cell
types that are capable of amplifying the
autoimmune response by recruiting addi-
tional immune cell populations (Kang
et al., 2010; Ogura et al., 2008). Thus, in
this scenario, Th17 cells serve to initiateand potentially sustain the recruitment
of a secondary pathogenic inflammatory
cell infiltrate that is directly responsible
for the demyelination and neuronal dam-
age underlying the physiological manifes-
tations of the disease (Figure 1).
The above model proposes a role for
Th17 cells in EAE that is in line with the
function of these cells during immune
responses to extracellular pathogens,
i.e., the IL-17-dependent recruitment of
immune cell types, such as neutrophils,
that directly eradicate the infectious
agent. However, Th17 cells likely have
additional unexpected roles in infection
and autoimmunity beyond these relatively
simplistic models. Indeed, studies have
indicated that IL-17A and IL-17F may
not be the major pathogenic cytokines in
certain EAE models, suggesting the exis-
tence of additional mechanisms by which
Th17 cells can modulate disease (Haak
et al., 2009).
In this issue of Immunity, Siffrin et al.,
based on their intravital imaging observa-
tions of Th17 cell behavior during EAE,
propose an intriguing model of Th17
cell-mediated pathogenesis involving
direct, antigen-independent T cell-neuron
interactions (Figure 1). Although several
studies have examined T cell dynamics
during EAE using intravital microscopy
Figure 1. Potential Contributions of Th17 Cells to EAE Pathogenesis
Several recent studies have suggested a multistep process of EAE initiation beginning with Th17 cell
recruitment to the CNS, perhaps through the choroid plexus (data not shown). Subsequent interactions
of these autoreactive T cells with APCs bearing myelin-derived antigens leads to expression of effector
molecules such as IL-17A. These cytokines can activate other CNS-resident cell types, such as astro-
cytes, to produce inflammatory chemokines and cytokines that drive a secondary wave of pathogenic
inflammatory cell infiltration. Siffrin et al. propose an additional mechanism of Th17 cell-mediated neuronal
dysfunction involving direct antigen-independent interactions between Th17 cells and neurons. The
mechanisms by which Th17 cells engaged in these interactions cause neuronal damage are unknown
but could involve direct activation of neurons by glutamate, resulting in excitotoxicitiy. Antigen-specific
interactions between Th17 cells and APCs may serve to sustain the local Th17 response, providing addi-
tional cells capable of engaging neurons. Nonautoreactive Th17 T cells specific for an irrelevant antigen
may alsomake contacts with neurons, although the extent to which these cells are normally present during
EAE inflammation and the functional consequences of these interactions are unknown.
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focused on elucidating the potential
differences among CD4+ effector T cell
subsets. Given the proposed roles for
both Th1 and Th17 cell during EAE (Jager
et al., 2009), the authors of the current
study set out to characterize the dynamic
behavior of these cell types in the
brainstems of mice induced to develop
EAE either through active immunization
with a myelin oligodendrocyte glycopro-
tein (MOG)-derived peptide or through
passive transfer of in vitro polarized
MOG-specific TCR transgenic Th17 cells
into RAG-deficient animals. Using mice
bearing fluorescent populations of neu-
rons and T cells, they found that com-
pared to in vitro polarized Th1 cells,
in vitro polarized Th17 cells appeared to
display differential migration dynamics
within the CNS, including a tendency to
form sustained contacts with axons.
These observations led the authors toinvestigate the potential consequences
of these T cell-neuron interactions. In vitro
studies involving coculture of neurons
with Th1 or Th17 cells suggested that
the later cell type may be preferentially
cytotoxic to neurons. In order to translate
these findings in vivo, the studywent on to
examine neuronal Ca2+ amounts using a
transgenic mouse bearing a FRET-based
Ca2+ sensor in neurons. Interestingly,
the authors found that neurons engaged
with Th17 cells appear to have higher
basal concentrations of Ca2+. These
increased Ca2+ concentrations could be
responsible for neuronal dysfunction
through excitotoxicity and were at least
partially reduced by addition of an
NMDA receptor antagonist, suggesting
the importance of glutamate in this
process. While the authors speculate
that the source of this glutamate could
be proximal Th17 cells themselves, given
the finding that a Na+ channel antagonistImmunity 33, Sewas also able to reduce Ca2+ concentra-
tions, it remains a possibility that neuronal
sources of glutamate are responsible for
the hyper-excited state and that Th17
cells regulate this process indirectly.
One of the key conclusions of this study
is that the extent of in vivo Th17-neuron
interactions and in vitro Th17-induced
neuron toxicity appears to be indepen-
dent of antigen specificity, as both MOG
and ovalbumin (OVA)-specific TCR trans-
genic T cells displayed these behaviors,
and MHC II expression by neurons
was not observed. These data suggest
that Th17 cells, by virtue of their unique
gene expression patterns, possess
some intrinsic affinity for neurons. Inter-
estingly, however, MOG-specific Th17
cells appeared to induce higher amounts
of Ca2+ in neurons compared to OVA-
specific Th17 cells, although the statis-
tical significance of this observation was
not clear in the present study, and in
contrast to MOG-specific Th17 cells,
adoptive transfer of OVA-specific Th17
cells into animals with active EAE did not
have an appreciable effect on disease
course. Thus, antigen recognition by
Th17 cells within the CNS does play a
critical role in the function of these cells,
perhaps by locally sustaining a source of
activated Th17 cell as suggested by the
authors, or through the T cell-mediated
production of factors that directly modu-
late the inflammatory environment within
the CNS (Figure 1).
Although the model proposed by Siffrin
et al. is certainly intriguing, as with any
initial finding, there are aspects that are
in need of refinement and further explora-
tion. The observation that Th1 and Th17
cells display different dynamics within
the CNS suggests that the differential
gene expression patterns inherent in
these cell types endow them with unique
abilities to migrate within interstitial
compartments of tissues. Elucidating
the specific pathways involved in these
differences and, more importantly, the
consequences of this differential behav-
ior for effector T cell function, will be
critical for our understanding of T cell
biology. The current study only reported
data limited to select pairings of T cell
antigen specificity (MOG versus OVA)
and differentiation state (Th1 versus
Th17) in their in vitro and in vivo studies,
thus precluding a more complete under-
standing of the role of antigen receptorptember 24, 2010 ª2010 Elsevier Inc. 299
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state in regulating T cell behavior and
neuronal interactions during EAE. An
additional area of exploration will involve
defining the nature of T cell-neuron inter-
actions. Based on the localization of the
T cell microtubule organizing center and
intracellular membrane compartments,
Siffrin et al. propose that a classical
immunological synapse (IS) may form
between these two cell types. However,
it remains to be determined whether
many of the hallmarks of IS formation
(e.g., actin polymerization, membrane
protein recruitment and segregation,
etc.) occur during T cell-neuron contacts
and what the upstream signals driving
these cellular events might be. Finally,
and perhaps most importantly, although
the presence of juxtaposed Th17 cells
loosely correlates with increased neu-
ronal Ca2+ concentrations, no causal rela-
tionship was established by the current
study. Indeed, a thorough quantification
of the Ca2+ concentration in neurons
with associated Th17 cells versus those
without was not performed. Thus, it
remains a distinct possibility that the
drivers of pathogenesis in this EAE model300 Immunity 33, September 24, 2010 ª2010are the Th17 cells seen making antigen-
specific contacts with MHC II+ cells and
that the presence of Th17 cells proximal
to neurons is simply a by-product of
an inflammatory responses involving
infiltration of large numbers of these
cells. Future studies aimed at defining
the molecular mechanisms underlying
Th17-neuron crosstalk and subsequent
experiments designed to address the
consequences of blocking these path-
ways on neuronal Ca2+ concentrations
and dysfunction should help to establish
the importance of these interactions for
disease. In addition, these next studies
could provide the basis for additional
investigations aimed at elucidating the
evolutionary basis for Th17-neuron inter-
actions, which likely would have arisen
as a by-product of an as of yet unknown
Th17 function that is important for the
immune response to infection.REFERENCES
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